Form 4 for AUPH Aurinia Pharmaceuticals Inc.
Accepted 2026-02-23 00:00:00 ET · period of report 2026-02-20 · accession 0001363683-26-000002 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-23 | 2026-02-20 | AUPH | Greenleaf Peter | CEO, Dir | F - Tax | $14.40 | -100.2K | 1.74M | -5% | -$1.44M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-20 | F | D | 100,171 | $14.40 | 1,744,866 | D | — | — | (F1) Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units. |